GOLDMAN SACHS GROUP INC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 84 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$12,179
+5.0%
97,669
-13.3%
0.00%
Q4 2022$11,603
-47.3%
112,646
-22.2%
0.00%
Q3 2022$22,000
-96.3%
144,832
-78.7%
0.00%
Q2 2022$598,000
-26.4%
679,596
+3.6%
0.00%
Q1 2022$813,000
-65.0%
655,782
-45.0%
0.00%
Q4 2021$2,324,000
-47.8%
1,191,461
-26.6%
0.00%
-100.0%
Q3 2021$4,450,000
+141.5%
1,624,246
+177.7%
0.00%
Q2 2021$1,843,000
+279.2%
584,902
+156.2%
0.00%
Q1 2021$486,000
+198.2%
228,308
+171.2%
0.00%
Q4 2020$163,000
+64.6%
84,175
-40.5%
0.00%
Q3 2020$99,000
+94.1%
141,356
+1061.2%
0.00%
Q3 2016$51,00012,1730.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders